NASDAQ:BBLG

Bone Biologics Stock Forecast

etoro logo Buy BBLG
*Your capital is at risk
$1.25
-0.0013 (-0.104%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of BBLG AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BBLG to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Bone Biologics Corporation stock downgraded from Sell Candidate to Strong Sell Candidate after Friday trading session
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 01, 2026 Loss -2.45%

The Bone Biologics Corporation stock price fell by -0.104% on the last day (Friday, 5th Jun 2026) from $1.25 to $1.25. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 2.85% from a day low at $1.23 to a day high of $1.27. The price has fallen in 7 of the last 10 days but is still up by 1.52% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -196 shares and in total, 17 thousand shares were bought and sold for approximately $20.70 thousand.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 6.92% during the next 3 months and, with a 90% probability hold a price between $1.23 and $1.55 at the end of this 3-month period.

BBLG Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Bone Biologics Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.28 and $1.30. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, April 22, 2026, and so far it has fallen -11.12%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Bone Biologics Corporation stock

Bone Biologics Corporation finds support from accumulated volume at $1.24 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved $0.0350 between high and low, or 2.85%. For the last week the stock has had daily average volatility of 4.54%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BBLG) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Bone Biologics Corporation to open at $1.25, and during the day (based on 14 day Average True Range), to move between $1.22 and $1.28, which gives a possible trading interval of +/-$0.0597 (+/-4.90%) up or down from last closing price. If Bone Biologics Corporation takes out the full calculated possible swing range there will be an estimated 4.90% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.24 (0.70%) than the resistance at $1.26 (0.90%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Bone Biologics Corporation stock A Buy?

The Bone Biologics Corporation stock holds several negative signals and despite the positive trend, we believe Bone Biologics Corporation will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.414 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $1.25 ( 0.0641%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BBLG Performance

Trading levels for BBLG

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.28 2.74%
R2 1.27 1.67%
R1 1.26 1.01%
Price 1.25
S1 1.23 -1.13%
S2 1.23 -1.80%
S3 1.21 -2.87%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.32 5.71%
R2 1.28 2.51%
R1 1.26 0.90%
Price 1.25
S1 1.24 -0.697%
S2 1.23 -1.50%
S3 1.22 -2.30%

FAQ

What is the symbol for Bone Biologics Corporation Stock and on which exchange is it traded?
The symbol for Bone Biologics Corporation is BBLG and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Bone Biologics Corporation Stock?
The Bone Biologics Corporation stock holds several negative signals and despite the positive trend, we believe Bone Biologics Corporation will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Bone Biologics Corporation Stock?
Bone Biologics Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bone Biologics Corporation Stock.

What's the current price of Bone Biologics Corporation Stock?
As of the end of day on the Jun 05, 2026, the price of an Bone Biologics Corporation (BBLG) share was $1.25.

What is the 52-week high and low for Bone Biologics Corporation Stock?
The 52-week high for Bone Biologics Corporation Stock is $6.75 and the 52-week low is $0.730.

What is the market capitalization of Bone Biologics Corporation Stock?
As of the Jun 05, 2026, the market capitalization of Bone Biologics Corporation is 2.242M.

When is the next earnings date for Bone Biologics Corporation?
The upcoming earnings date for Bone Biologics Corporation is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT BONE BIOLOGICS CORPORATION
Bone Biologics
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE